Neurologic manifestations are rarely described in hereditary hemochromatosi
s (HH). We describe three patients with HH and movement disorders. Patient
1, a 69-year-old man, had a 13-year history of disabling cerebellar syndrom
e, action tremor and myoclonus, and secondary dementia. Patient 2 was a 40-
year-old man with a 9-year history of cerebellar syndrome, head and arm tre
mor, and cervical dystonia. Patient 3, a 75-year-old woman, had a 5-year hi
story of rapidly disabling parkinsonian syndrome unresponsive to levodopa.
The diagnosis of HH was established in the three patients by iron tests, ev
idence of a C282Y mutation, and, in two patients, by liver biopsy. High-fie
ld T2-weighted magnetic resonance imaging showed hyperintense signals in he
mispheric white matter in patient 1, cerebellar atrophy in patient 2, and c
erebellar and cerebral atrophy in patient 3 and no significant hypointense
signals in the three patients. Phlebotomies and symptomatic treatments did
not change the course of the disease. Our cases are compared with the five
previously reported observations of HH with movement disorders. This rare a
ssociation is one cause of the chronic acquired non-Wilsonian hepatocerebra
l degeneration syndromes and represents a separate entity from aceruloplasm
inemia. The pathophysiologic mechanism of movement disorders in HH is unres
olved. No hepatic insufficiency and portosystemic encephalopathy is evidenc
ed in our cases, whereas the putative role of abnormal iron load remains to
be ascertained. HH should be investigated more systematically in patients
with movement disorders.